Kamrava, Mitchell
Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. [electronic resource]
- Oncogene Oct 2005
- 7084-93 p. digital
Publication Type: Journal Article
ISSN: 0950-9232
Standard No.: 10.1038/sj.onc.1208857 doi
Subjects--Topical Terms: Adjuvants, Immunologic--pharmacology Apoptosis--drug effects Blotting, Northern Blotting, Western Caspase 3 Caspases--metabolism Cell Nucleus--drug effects Cell Proliferation--drug effects Chelating Agents--pharmacology Cholera Toxin--pharmacology Colforsin--pharmacology Cyclic AMP--metabolism Cyclic AMP-Dependent Protein Kinases--metabolism Egtazic Acid--analogs & derivatives Endothelins--pharmacology Female Guanine Nucleotide Exchange Factors--metabolism Humans Intercellular Signaling Peptides and Proteins--chemistry Lysophospholipids--pharmacology MAP Kinase Kinase 1--metabolism Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3--metabolism Ovarian Neoplasms--metabolism Pertussis Toxin--pharmacology Poly(ADP-ribose) Polymerases--metabolism Progranulins Tumor Cells, Cultured